Company intelligence / Profile preview

Serica Technologies

Medford, MA, United Statesserica-watches.com ↗

Ownership: Private
Development stage: Commercial

Overview

Serica’s silk-based scaffolds demonstrated safety and efficacy in preclinical animal models and early human clinical trials. The SeriACL device showed promising results as a bioresorbable scaffold supporting ligament regeneration with normal function restored in most cases by six months post-surgery. The company received FDA clearance for its silk mesh product ("SeriScaffold") prior to acquisition.

Therapeutic areas: Other
Modalities: DeviceBiologic
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Serica Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serica Technologies.

Explore the full profile